NHS England has approved funding for more than 160 additional GP surgery-based clinical pharmacists able to offer expert medical advice and treatment to patients. More: NHS England to fund more GP-based pharmacists Source: News
read moreThe first verdict to go against Bayer and Johnson & Johnson over Xarelto’s bleeding risks didn’t stand up to court scrutiny. A U.S. judge overturned the $28 million award on grounds it was an unreasonable result. More: Plaintiff's Xarelto victory
read morePeople often ask Bristol-Myers Squibb CEO Giovanni Caforio how much growth is still ahead for Eliquis, the next-gen anticoagulant the company shares with Pfizer. His answer? Plenty. More: After 5 years, Eliquis' growth ceiling is nowhere in sight: Bristol-Myers CEO
read moreTeva has worked out agreements with workers to close another plant in Israel. That is two down and about 40 to go. More: Teva to cut up to 40 manufacturing sites, with 25 slated to go in next 2 years
read moreAlexion’s rollout of Soliris in generalized myasthenia gravis won’t be just any launch for the rare-disease product. The company thinks it can make the kickoff its best ever. More: Alexion aims for best-ever Soliris launch with new myasthenia gravis indication
read moreThe time when pharma fully embraces tech is still very far off, despite some optimistic comments from executives at JPM. So far, in fact, “no one can see it at the moment,” one expert told us. It’s more likely that
read more© 1994 - 2026 B.M. Pharmaceuticals